Literature DB >> 23812461

Tubal factor infertility and perinatal risk after assisted reproductive technology.

Jennifer F Kawwass1, Sara Crawford, Dmitry M Kissin, Donna R Session, Sheree Boulet, Denise J Jamieson.   

Abstract

OBJECTIVE: To assess trends of tubal factor infertility and to evaluate risk of miscarriage and delivery of preterm or low birth weight (LBW) neonates among women with tubal factor infertility using assisted reproductive technology (ART).
METHODS: We assessed trends of tubal factor infertility among all fresh and frozen, donor, and nondonor ART cycles performed annually in the United States between 2000 and 2010 (N=1,418,774) using the National ART Surveillance System. The data set was then limited to fresh, nondonor in vitro fertilization cycles resulting in pregnancy to compare perinatal outcomes for cycles associated with tubal compared with male factor infertility. We performed bivariate and multivariable analyses controlling for maternal characteristics and calculated adjusted risk ratios (RRs) and 95% confidence intervals (CI).
RESULTS: The percentage of ART cycles associated with tubal factor infertility diagnoses decreased from 2000 to 2010 (26.02-14.81%). Compared with male factor infertility, tubal factor portended an increased risk of miscarriage (14.0% compared with 12.7%, adjusted RR 1.08, 95% CI 1.04-1.12); risk was increased for both early and late miscarriage. Singleton neonates born to women with tubal factor infertility had an increased risk of preterm birth (15.8% compared with 11.6%, adjusted RR 1.27, 95% CI 1.20-1.34) and LBW (10.9% compared with 8.5%, adjusted RR 1.28, 95% CI 1.20-1.36). Significant increases in risk persisted for early and late preterm delivery and very low and moderately LBW delivery. A significantly elevated risk was also detected for twin, but not triplet, pregnancies.
CONCLUSION: Tubal factor infertility, which is decreasing in prevalence in the United States, is associated with an increased risk of miscarriage, preterm birth, and LBW delivery as compared with couples with male factor infertility using ART.

Entities:  

Mesh:

Year:  2013        PMID: 23812461      PMCID: PMC4292839          DOI: 10.1097/AOG.0b013e31829006d9

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.623


  23 in total

1.  Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies.

Authors:  E Camus; C Poncelet; F Goffinet; B Wainer; F Merlet; I Nisand; H J Philippe
Journal:  Hum Reprod       Date:  1999-05       Impact factor: 6.918

2.  Hydrosalpinges adversely affect implantation in donor oocyte cycles.

Authors:  M A Cohen; S R Lindheim; M V Sauer
Journal:  Hum Reprod       Date:  1999-04       Impact factor: 6.918

3.  Easy SAS calculations for risk or prevalence ratios and differences.

Authors:  Donna Spiegelman; Ellen Hertzmark
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

Review 4.  Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses.

Authors:  Sarah D McDonald; Zhen Han; Sohail Mulla; Kellie E Murphy; Joseph Beyene; Arne Ohlsson
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-07-04       Impact factor: 2.435

5.  Public reporting of clinical outcomes of assisted reproductive technology programs: implications for other medical and surgical procedures.

Authors:  Eli Y Adashi; Ron Wyden
Journal:  JAMA       Date:  2011-09-14       Impact factor: 56.272

6.  Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women.

Authors:  Denise L Jacobson; Tamsin Knox; Donna Spiegelman; Sally Skinner; Sherwood Gorbach; Christine Wanke
Journal:  Clin Infect Dis       Date:  2005-05-06       Impact factor: 9.079

Review 7.  Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract.

Authors:  Iara Moreno Linhares; Steven S Witkin
Journal:  Cell Stress Chaperones       Date:  2010-02-25       Impact factor: 3.667

8.  Trends and correlates of good perinatal outcomes in assisted reproductive technology.

Authors:  Nikhil Joshi; Dmitry Kissin; John E Anderson; Donna Session; Maurizio Macaluso; Denise J Jamieson
Journal:  Obstet Gynecol       Date:  2012-10       Impact factor: 7.661

9.  Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates.

Authors:  A Strandell; U Waldenström; L Nilsson; L Hamberger
Journal:  Hum Reprod       Date:  1994-05       Impact factor: 6.918

Review 10.  Antichlamydial antibodies, human fertility, and pregnancy wastage.

Authors:  Amanda J Stephens; Mira Aubuchon; Danny J Schust
Journal:  Infect Dis Obstet Gynecol       Date:  2011-09-22
View more
  18 in total

1.  Assisted reproduction and risk of preterm birth in singletons by infertility diagnoses and treatment modalities: a population-based study.

Authors:  Galit Levi Dunietz; Claudia Holzman; Yujia Zhang; Chenxi Li; David Todem; Sheree L Boulet; Patricia McKane; Dmitry M Kissin; Glenn Copeland; Dana Bernson; Michael P Diamond
Journal:  J Assist Reprod Genet       Date:  2017-07-28       Impact factor: 3.412

2.  Population-attributable fraction of tubal factor infertility associated with chlamydia.

Authors:  Rachel J Gorwitz; Harold C Wiesenfeld; Pai-Lien Chen; Karen R Hammond; Karen A Sereday; Catherine L Haggerty; Robert E Johnson; John R Papp; Dmitry M Kissin; Tara C Henning; Edward W Hook; Michael P Steinkampf; Lauri E Markowitz; William M Geisler
Journal:  Am J Obstet Gynecol       Date:  2017-05-19       Impact factor: 8.661

3.  Maternal Racial and Ethnic Disparities in Neonatal Birth Outcomes With and Without Assisted Reproduction.

Authors:  Sara Crawford; Nikhil Joshi; Sheree L Boulet; Marie A Bailey; Maria-Elena Hood; Susan E Manning; Patricia McKane; Russell S Kirby; Dmitry M Kissin; Denise J Jamieson
Journal:  Obstet Gynecol       Date:  2017-06       Impact factor: 7.661

4.  Arabian Peninsula ethnicity is associated with lower ovarian reserve and ovarian response in women undergoing fresh ICSI cycles.

Authors:  Aya M Tabbalat; Nigel Pereira; Devon Klauck; Clara Melhem; Rony T Elias; Zev Rosenwaks
Journal:  J Assist Reprod Genet       Date:  2017-10-23       Impact factor: 3.412

5.  Association of assisted reproductive technology (ART) treatment and parental infertility diagnosis with autism in ART-conceived children.

Authors:  D M Kissin; Y Zhang; S L Boulet; C Fountain; P Bearman; L Schieve; M Yeargin-Allsopp; D J Jamieson
Journal:  Hum Reprod       Date:  2014-12-17       Impact factor: 6.918

6.  Supply of and demand for assisted reproductive technologies in the United States: clinic- and population-based data, 1995-2010.

Authors:  Elizabeth Hervey Stephen; Anjani Chandra; Rosalind Berkowitz King
Journal:  Fertil Steril       Date:  2015-10-24       Impact factor: 7.329

7.  Birth Outcomes by Infertility Diagnosis Analyses of the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART).

Authors:  Barbara Luke; Judy E Stern; Milton Kotelchuck; Eugene R Declercq; Bruce Cohen; Hafsatou Diop
Journal:  J Reprod Med       Date:  2015 Nov-Dec       Impact factor: 0.142

8.  Evaluating effects of prenatal exposure to phthalate mixtures on birth weight: A comparison of three statistical approaches.

Authors:  Yu-Han Chiu; Andrea Bellavia; Tamarra James-Todd; Katharine F Correia; Linda Valeri; Carmen Messerlian; Jennifer B Ford; Lidia Mínguez-Alarcón; Antonia M Calafat; Russ Hauser; Paige L Williams
Journal:  Environ Int       Date:  2018-02-20       Impact factor: 9.621

9.  Embryo banking among women diagnosed with cancer: a pilot population-based study in New York, Texas, and Illinois.

Authors:  Barbara Luke; Morton B Brown; Logan G Spector; Judy E Stern; Yolanda R Smith; Melanie Williams; Lori Koch; Maria J Schymura
Journal:  J Assist Reprod Genet       Date:  2016-02-03       Impact factor: 3.412

10.  Trends and outcomes for donor oocyte cycles in the United States, 2000-2010.

Authors:  Jennifer F Kawwass; Michael Monsour; Sara Crawford; Dmitry M Kissin; Donna R Session; Aniket D Kulkarni; Denise J Jamieson
Journal:  JAMA       Date:  2013-12-11       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.